Enorama Pharma AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 0.032 million compared to SEK 4.63 million a year ago. Negative revenue was SEK 0.282 million compared to revenue of SEK 3.7 million a year ago. Net loss was SEK 11.15 million compared to SEK 8.05 million a year ago.
For the full year, sales was SEK 6.85 million compared to SEK 12.8 million a year ago. Revenue was SEK 9.44 million compared to SEK 12.95 million a year ago. Net loss was SEK 40.08 million compared to SEK 27.74 million a year ago.